BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 15269597)

  • 1. Metastasis suppressor genes: a role for raf kinase inhibitor protein (RKIP).
    Keller ET
    Anticancer Drugs; 2004 Aug; 15(7):663-9. PubMed ID: 15269597
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Raf kinase inhibitor protein: a prostate cancer metastasis suppressor gene.
    Keller ET; Fu Z; Yeung K; Brennan M
    Cancer Lett; 2004 Apr; 207(2):131-7. PubMed ID: 15151133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raf kinase inhibitor protein (RKIP) deficiency decreases latency of tumorigenesis and increases metastasis in a murine genetic model of prostate cancer.
    Escara-Wilke J; Keller JM; Ignatoski KM; Dai J; Shelley G; Mizokami A; Zhang J; Yeung ML; Yeung KC; Keller ET
    Prostate; 2015 Feb; 75(3):292-302. PubMed ID: 25327941
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The biology of a prostate cancer metastasis suppressor protein: Raf kinase inhibitor protein.
    Keller ET; Fu Z; Brennan M
    J Cell Biochem; 2005 Feb; 94(2):273-8. PubMed ID: 15565643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of raf kinase inhibitor protein expression on suppression of prostate cancer metastasis.
    Fu Z; Smith PC; Zhang L; Rubin MA; Dunn RL; Yao Z; Keller ET
    J Natl Cancer Inst; 2003 Jun; 95(12):878-89. PubMed ID: 12813171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metastasis suppressor gene Raf kinase inhibitor protein (RKIP) is a novel prognostic marker in prostate cancer.
    Fu Z; Kitagawa Y; Shen R; Shah R; Mehra R; Rhodes D; Keller PJ; Mizokami A; Dunn R; Chinnaiyan AM; Yao Z; Keller ET
    Prostate; 2006 Feb; 66(3):248-56. PubMed ID: 16175585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-543 Promotes Proliferation and Epithelial-Mesenchymal Transition in Prostate Cancer via Targeting RKIP.
    Du Y; Liu XH; Zhu HC; Wang L; Ning JZ; Xiao CC
    Cell Physiol Biochem; 2017; 41(3):1135-1146. PubMed ID: 28245474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Raf kinase inhibitor protein (RKIP) in cancer.
    Escara-Wilke J; Yeung K; Keller ET
    Cancer Metastasis Rev; 2012 Dec; 31(3-4):615-20. PubMed ID: 22684368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
    Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
    Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of Raf kinase inhibitory protein induces radioresistance in prostate cancer.
    Woods Ignatoski KM; Grewal NK; Markwart SM; Vellaichamy A; Chinnaiyan AM; Yeung K; Ray ME; Keller ET
    Int J Radiat Oncol Biol Phys; 2008 Sep; 72(1):153-60. PubMed ID: 18722266
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of Raf kinase inhibitor protein (RKIP) in health and disease.
    Keller ET; Fu Z; Brennan M
    Biochem Pharmacol; 2004 Sep; 68(6):1049-53. PubMed ID: 15313400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RKIP Inhibits Local Breast Cancer Invasion by Antagonizing the Transcriptional Activation of MMP13.
    Datar I; Feng J; Qiu X; Lewandowski J; Yeung M; Ren G; Aras S; Al-Mulla F; Cui H; Trumbly R; Arudra SK; De Las Casas LE; de la Serna I; Bitar MS; Yeung KC
    PLoS One; 2015; 10(8):e0134494. PubMed ID: 26308852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction of Raf-1 kinase inhibitor protein expression correlates with breast cancer metastasis.
    Hagan S; Al-Mulla F; Mallon E; Oien K; Ferrier R; Gusterson B; GarcĂ­a JJ; Kolch W
    Clin Cancer Res; 2005 Oct; 11(20):7392-7. PubMed ID: 16243812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Killing two birds with one RKIP.
    Goel R; Baldassare JJ
    Trends Endocrinol Metab; 2004 Apr; 15(3):91-2. PubMed ID: 15146872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Raf kinase inhibitory protein suppresses a metastasis signalling cascade involving LIN28 and let-7.
    Dangi-Garimella S; Yun J; Eves EM; Newman M; Erkeland SJ; Hammond SM; Minn AJ; Rosner MR
    EMBO J; 2009 Feb; 28(4):347-58. PubMed ID: 19153603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Raf kinase inhibitor protein inhibits esophageal cancer cell invasion through downregulation of matrix metalloproteinase expression.
    Zhao D; Ma J; Shi J; Cheng L; Li F; Jiang X; Jiang H
    Oncol Rep; 2013 Jul; 30(1):304-12. PubMed ID: 23674108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of epithelial to mesenchymal transition in metastatic prostate cancer cells by the novel proteasome inhibitor, NPI-0052: pivotal roles of Snail repression and RKIP induction.
    Baritaki S; Chapman A; Yeung K; Spandidos DA; Palladino M; Bonavida B
    Oncogene; 2009 Oct; 28(40):3573-85. PubMed ID: 19633685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SEC-induced activation of ANXA7 GTPase suppresses prostate cancer metastasis.
    Liu S; Li X; Lin Z; Su L; Yan S; Zhao B; Miao J
    Cancer Lett; 2018 Mar; 416():11-23. PubMed ID: 29247827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor suppressor RKIP inhibits prostate cancer cell metastasis and sensitizes prostate cancer cells to docetaxel treatment.
    Zhu CX; Li WZ; Guo YL; Chen L; Li GH; Yu JJ; Shu B; Peng S
    Neoplasma; 2018; 65(2):228-233. PubMed ID: 29534584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of RKIP expression promotes nasopharyngeal carcinoma invasion and metastasis by activating Stat3 signaling.
    He QY; Yi HM; Yi H; Xiao T; Qu JQ; Yuan L; Zhu JF; Li JY; Wang YY; Li LN; Feng J; Lu SS; Xiao ZQ
    Oncotarget; 2015 Jun; 6(18):16422-36. PubMed ID: 25915430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.